合成路线1
该中间体在本合成路线中的序号:
(V) The oxidation of 3-beta-acetoxyolean-12-en-30-oic acid methyl ester (I) with H2O2 in hot acetic acid gives 3beta-acetoxy-12-oxoolean-30-oic acid methyl ester (II), which is treated with Br2 in 40% HBr acetic acid yielding 3beta-acetoxy-12-oxoolean 9-en-30-oic acid methyl ester (III). The reduction of (III) with hydrazine and sodium ethoxide in ethanol affords 3beta-hydroxyolean-9(11)-en-30-oic acid (IV), which is finally esterified with succinic anhydride (V) in hot pyridine.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23967 |
(2S,4aS,6aR,6bR,8aR,10S,12aR,14bR)-10-(acetoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-2-picenyl acetate
|
|
C33H52O4 |
详情 |
详情
|
(II) |
23980 |
(2S,4aS,6aR,6bR,8aR,10S,12aR,14aR,14bS)-10-(acetoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-14-oxodocosahydro-2-picenyl acetate
|
|
C33H52O5 |
详情 |
详情
|
(III) |
23968 |
(2S,4aS,6aR,6bS,8aR,10S,12aS,14aR,14bS)-10-(acetoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-2-picenyl acetate
|
|
C33H50O5 |
详情 |
详情
|
(IV) |
23969 |
(2S,4aS,6aR,6bS,8aR,10S,12aS,14aR,14bS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-2-picenecarboxylic acid
|
|
C30H48O3 |
详情 |
详情
|
(V) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The condensation of benzoin (I) with succinic anhydride (II) by heating at 120 C gives benzoin hemisuccinate (III), which is cyclized with ammonium acetate in refluxing acetic acid.
【1】
Brown, K. (Wyeth-Ayerst Laboratories); Oxazoles. GB 1206403; YU 244367; YU 249673 .
|
【2】
Brown, K. (Wyeth-Ayerst Laboratories); Oxazoles. US 3578671 .
|
【3】
Arrigoni-Martelli, E.; Castaner, J.; Oxaprozin. Drugs Fut 1978, 3, 7, 539.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24135 |
2-hydroxy-1,2-diphenyl-1-ethanone; benzoin
|
579-44-2 |
C14H12O2 |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
33528 |
4-oxo-4-(2-oxo-1,2-diphenylethoxy)butyric acid
|
|
C18H16O5 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(B) The esterification of 4-phenoxy-3-nitro-5-sulfamoylbenzoic acid (I) with methanol and H2SO4 gives the corresponding methyl ester (II), which is reduced with H2 over Raney-Ni in methanol yielding methyl 4-phenoxy-3-amino-5-sulfamoylbenzoate (III). The condensation of (III) with succinic anhydride (B) or succinoyl chloride (A) by means of pyridine in refluxing dioxane affords methyl 4-phenoxy-3N-succinimido-5-sulfamoylbenzoate (IV), which is reduced with borontrifluoride ethearate and NaBH4 in diglyme giving methyl 4-phenoxy-3-(1-pyrrolidinyl)-5-sulfamoylbenzoate (V). Finally, this compound is hydrolyzed with NaOH in water.
【1】
Merkel, W.; et al.; Piretanide (Hoe 118) a new high ceiling salidiuretic. Eur J Med Chem 1976, 11, 5, 399.
|
【2】
Bormann, D.; et al.; 5-Sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent. DE 2419970; FR 2324298; GB 1504505; US 4010273 .
|
【3】
Hillier, K.; Castaner, J.; Piretanide. Drugs Fut 1977, 2, 6, 393.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(A) |
33879 |
succinoyl dichloride
|
543-20-4 |
C4H4Cl2O2 |
详情 | 详情
|
(I) |
33876 |
3-(aminosulfonyl)-5-nitro-4-phenoxybenzoic acid
|
|
C13H10N2O7S |
详情 |
详情
|
(II) |
33877 |
methyl 3-(aminosulfonyl)-5-nitro-4-phenoxybenzoate
|
|
C14H12N2O7S |
详情 |
详情
|
(III) |
33878 |
methyl 3-amino-5-(aminosulfonyl)-4-phenoxybenzoate
|
|
C14H14N2O5S |
详情 |
详情
|
(IV) |
33880 |
methyl 3-(aminosulfonyl)-5-(2,5-dioxo-1-pyrrolidinyl)-4-phenoxybenzoate
|
|
C18H16N2O7S |
详情 |
详情
|
(V) |
33881 |
methyl 3-(aminosulfonyl)-4-phenoxy-5-(1-pyrrolidinyl)benzoate
|
|
C18H20N2O5S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) By acylation of 1-ethyl-6-fluoro-4-oxo-7-piperazine-1,4-dihydroquinoline-3-carboxylic acid (I) with succinic anhydride (II) in refluxing dichloromethane. Acetic acid can also be used as solvent in the acylation.
【1】
Di Schiena, M. (Farmades); Cpds. having antibacterial activity, process for their preparation and pharmaceutical compsns. Containing them. EP 0155006 .
|
【2】
Prous, J.; Castaner, J.; NORFLOXACIN SUCCINIL. Drugs Fut 1990, 15, 6, 578.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11290 |
1-Ethyl-6-fluoro-4-oxo-7-piperazino-1,4-dihydro-3-quinolinecarboxylic acid; Norfloxacin
|
70458-96-7 |
C16H18FN3O3 |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(A) Rearrangement of 2-methylpropanoic acid, 2-phenylhydrazide (I) provides 1,3-dihydro-3,3-dimethyl-2H-indol-2-one (II). Friedel Crafts' acylation of (II) with succinic anhydride in an aluminum chloride/DMF melt results in the formation of 4-oxobutanoic acid (III). Cyclization of (III) with hydrazine in refluxing ethanol completes the preparation of LY-195115.
【1】
Hayes, J.S.; Robertson, D.W.; LY-195115
. Drugs Fut 1986, 11, 5, 377.
|
【2】
Robertson, D.W.; et al.; Dihydropyridazinone cardiotonics: The discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one. J Med Chem 1986, 29, 10, 1832-40.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(I) |
24021 |
2-methyl-N'-phenylpropanohydrazide
|
|
C10H14N2O |
详情 |
详情
|
(II) |
21599 |
3,3-dimethyl-1,3-dihydro-2H-indol-2-one
|
|
C10H11NO |
详情 |
详情
|
(III) |
24024 |
4-(3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-4-oxobutyric acid
|
|
C14H15NO4 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(B) The reaction of 1-amino-5-nitropentane (I) with benzyloxycarbonyl chloride (A) by means of NaOH in water gives 1-carbobenzoxyamino-5-nitropentane (II), which by reduction with Zn and ammonium chloride in ethanol - water yields 1-carbobenzoxyamino-5-hydroxylaminopentane (III). The reaction of (III) with succinic anhydride (B) by means of NaOH in pyridine water affords 1-carbobenzoxyamino-5-(N-succinylhydroxylamino)pentane (IV), which is cyclized with hot acetic anhydride giving 2-(5-carbobenzoxyaminopentyl)-3,6-dioxotetrahydro-1,2-oxazine (V). The reaction of (V) with the nitroamine (I) by means of sodium methoxide in methanol yields 1-carbobenzoxy-6-hydroxy-16-nitro-7,10-dioxo-6,11-diazahexadecane (VI), which is reduced with Zn and acetylated as before affording 1-carboxybenzoxyamino-6-hydroxy-16-(N-acetylhydroxylamino)-7,10-dioxo-6,11-diazahexadecane (VII).
【1】
Prelog, V.; Walser, A.; 75. Stoffweschselprodukte con actinomyceten. Uber die synthese der ferrioxamine B und D1. Helv Chim Acta 1962, 45, 631-637.
|
【2】
Bickel, H.; et al.; 153. Stoffweschselprodukte von mikroorganismen. Zur henntnis von desferrioxamin B. Helv Chim Acta 1963, 46, 1385-89.
|
【3】
Blancafort, P.; Castaner, J.; Serradell, M.N.; Hopkins, S.J.; Liposome-Entrapped Desferrioxamine deferoxamine. Drugs Fut 1979, 4, 7, 500.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(A) |
24261 |
1-[2-(chlorooxy)-2-oxoethyl]benzene
|
|
C8H7ClO2 |
详情 |
详情
|
(I) |
33387 |
5-nitropentylamine; 5-nitro-1-pentanamine
|
|
C5H12N2O2 |
详情 |
详情
|
(II) |
33388 |
benzyl 5-nitropentylcarbamate
|
|
C13H18N2O4 |
详情 |
详情
|
(III) |
33389 |
benzyl 5-(hydroxyamino)pentylcarbamate
|
|
C13H20N2O3 |
详情 |
详情
|
(IV) |
33390 |
4-[(5-[[(benzyloxy)carbonyl]amino]pentyl)(hydroxy)amino]-4-oxobutyric acid
|
|
C17H24N2O6 |
详情 |
详情
|
(V) |
33391 |
benzyl 5-(3,6-dioxo-1,2-oxazinan-2-yl)pentylcarbamate
|
|
C17H22N2O5 |
详情 |
详情
|
(VI) |
33392 |
benzyl 5-(hydroxy[4-[(5-nitropentyl)amino]-4-oxobutanoyl]amino)pentylcarbamate
|
|
C22H34N4O7 |
详情 |
详情
|
(VII) |
33393 |
benzyl 5-[[4-([5-[acetyl(hydroxy)amino]pentyl]amino)-4-oxobutanoyl](hydroxy)amino]pentylcarbamate
|
|
C24H38N4O7 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) A new synthesis of tepoxalin has been described:
The condensation of 4-chloroacetophenone (I) with succinic anhydride (II) by means of lithium bis(trimethylsilyl)amide in THF at -20 C gives 6-(4-chlorophenyl)-4,6-dioxohexanoic acid (III), which is cyclized with 4-methoxyphenylhydrazine (IV) by means of triethylamine in methanol at room temperature to afford 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]propanoic acid (V); finally this compound is condensed with methylhydroxylamine (VI) by means of oxalyl chloride and triethylamine at room temperature.
【1】
Forerokelly, Y.; Murray, W.; Wachter, M.; Barton, D.; The regioselective synthesis of tepoxalin, 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-pyrazolyl]-N-hydroxy-N-methylpropanamide and related 1,5-diarylpyrazole antiinflammatory agents. Synthesis 1991, 1, 1, 18. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12685 |
4-Chloroacetophenone; 1-(4-Chlorophenyl)-1-ethanone; p-Chloroacetophenone
|
99-91-2 |
C8H7ClO |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
12687 |
6-(4-Chlorophenyl)-4,6-dioxohexanoic acid
|
|
C12H11ClO4 |
详情 |
详情
|
(IV) |
12688 |
4-Hydrazinophenyl methyl ether; 1-(4-Methoxyphenyl)hydrazine
|
3471-32-7 |
C7H10N2O |
详情 | 详情
|
(V) |
12689 |
3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl]propionic acid
|
|
C19H17ClN2O3 |
详情 |
详情
|
(VI) |
12690 |
(Hydroxyamino)methane; N-Methylhydroxylamine
|
593-77-1 |
CH5NO |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) A new synthesis of roxindole has been described: The condensation of 5-methoxyindole (I) with succinic anhydride (II) by means of methylmagnesium bromide in hot anisole gives the 4-oxobutyric acid derivative (III), which is condensed with the 4-phenyltetrahydropyridine (IV) by means of EDC and DIPEA in DMF yielding the butanedione (V). The reduction of (V) with LiAlH4 in refluxing THF affords intermediate (VI), which is finally demethylated with DIBAH in refluxing toluene.
【1】
Lange, J.H.M.; et al.; A straightforward synthetic approach for roxindole. Bioorg Med Chem Lett 1999, 9, 7, 1055.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
30614 |
4-(5-methoxy-1H-indol-3-yl)-4-oxobutyric acid
|
|
C13H13NO4 |
详情 |
详情
|
(IV) |
13002 |
4-Phenyl-1,2,3,6-tetrahydropyridine; 1,2,3,6-Tetrahydro-4-phenyl-pyridine
|
10338-69-9 |
C11H13N |
详情 | 详情
|
(V) |
30615 |
1-(5-methoxy-1H-indol-3-yl)-4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]-1,4-butanedione
|
|
C24H24N2O3 |
详情 |
详情
|
(VI) |
12999 |
5-Methoxy-3-[4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butyl]-1H-indole; Methyl 3-[4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butyl]-1H-indol-5-yl ether
|
|
C24H28N2O |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(V) The reaction of 2-hydroxy-3'-methoxybibenzyl (I) with epichlorohydrin (II) by means of NaH in DMF gives 2-(2,3-epoxypropoxy)-3'-methoxybibenzyl (III), which by reaction with dimethylamine in refluxing THF yields 2-[3-(dimethylamino)-2-hydroxypropoxy]-3'-methoxybibenzyl (IV). Finally, this compound is treated with succinic anhydride (V) in refluxing THF and with HCl in acetone.
【1】
Kikumoto, R.; Fukami, H.; Hara, H.; Ninomiya, K.; Sugano, M. (Mitsubishi Chemical Corp.); Pharmaceutically active (3-aminopropoxy)-bibenzyl derivs. EP 0072942 .
|
【2】
Prous, J.; Castaner, J.; Sarpogrelate Hydrochloride. Drugs Fut 1992, 17, 12, 1093.
|
【3】
Osakabe, M.; Fukami, H.; Sugano, M.; Kikumoto, R.; Ninomiya, K.; Tamao, Y.; Hara, H.; Syntheses and platelet aggregation inhibitory and antithrombotic properties of [2-[(omega-aminoalkoxy)phenyl]ethyl]benzenes. J Med Chem 1990, 33, 6, 1818.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
13604 |
2-(3-Methoxyphenethyl)phenol
|
|
C15H16O2 |
详情 |
详情
|
(III) |
13605 |
2-(3-Methoxyphenethyl)phenyl 2-oxiranylmethyl ether; 2-[[2-(3-Methoxyphenethyl)phenoxy]methyl]oxirane
|
|
C18H20O3 |
详情 |
详情
|
(IV) |
13606 |
1-(Dimethylamino)-3-[2-(3-methoxyphenethyl)phenoxy]-2-propanol
|
|
C20H27NO3 |
详情 |
详情
|
(V) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(XIV) The esterification of pyridine-2,5-dicarboxylic acid (I) with thionyl chloride/methanol gives the corresponding dimethyl ester (II), which is hydrogenated with H2 over PtO2 in acetic acid yielding piperidine-2,5-dicarboxylic acid dimethyl ester (III), as a mixture of the cis- and trans-isomers. The condensation of (III) with 2-chloroacetonitrile (IV) by means of Na2CO3 in refluxing isobutyl methyl ketone affords the expected 1-(cyanomethyl) derivative (V), which is cyclized by hydrogenation with H2 over RaNi in methanol/ethyl acetate giving racemic cis-1-oxo-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic acid methyl ester (VI). The reduction of (VI) with LiAlH4 in refluxing THF yields the corresponding hydroxymethyl derivative (VII), which is condensed with 2-chloropyrimidine by means of Na2CO3 in refluxing water affording racemic cis-7-(hydroxymethyl)-2-(2-pyrimidinyl)-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazine (IX). The reaction of (IX) with methanesulfonyl chloride and triethylamine gives the expected mesylate (X), which is treated with sodium azide in DMF to afford the corresponding azido derivative (XI). The reaction of (XI) with hydrazine in refluxing ethanol gives the racemic cis-7-(aminomethyl)-2-(2-pyrimidinyl)-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazine (XII), which is submitted to optical resolution by formation of the corresponding salt with (-)-mandelic acid, separation of the diastereomers by crystallization, and decomposition of the desired salt with NaOH to yield (7R,9aS)-7-(aminomethyl)-2-(2-pyrimidinyl)-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazine (XIII). Finally, this compound is condensed with succinic anhydride (XIV) in refluxing xylene.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14440 |
2,5-pyridinedicarboxylic acid
|
100-26-5 |
C7H5NO4 |
详情 | 详情
|
(II) |
14441 |
dimethyl 2,5-pyridinedicarboxylate
|
881-86-7 |
C9H9NO4 |
详情 | 详情
|
(III) |
14442 |
dimethyl 2,5-piperidinedicarboxylate
|
|
C9H15NO4 |
详情 |
详情
|
(IV) |
14443 |
2-chloroacetonitrile; chloroacetonitrile
|
107-14-2 |
C2H2ClN |
详情 | 详情
|
(V) |
14444 |
dimethyl 1-(cyanomethyl)-2,5-piperidinedicarboxylate
|
|
C11H16N2O4 |
详情 |
详情
|
(VI) |
14445 |
methyl (7S,9aS)-1-oxooctahydro-2H-pyrido[1,2-a]pyrazine-7-carboxylate
|
|
C10H16N2O3 |
详情 |
详情
|
(VII) |
14446 |
(7S,9aS)octahydro-2H-pyrido[1,2-a]pyrazin-7-ylmethanol
|
|
C9H18N2O |
详情 |
详情
|
(VIII) |
11191 |
2-Chloropyrimidine
|
1722-12-9 |
C4H3ClN2 |
详情 | 详情
|
(IX) |
14448 |
[(7S,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methanol
|
|
C13H20N4O |
详情 |
详情
|
(X) |
14449 |
[(7S,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methyl methanesulfonate
|
|
C14H22N4O3S |
详情 |
详情
|
(XI) |
14450 |
[(7S,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methyl azide; (7S,9aS)-7-(azidomethyl)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazine
|
|
C13H19N7 |
详情 |
详情
|
(XII) |
63830 |
[(7S,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methylamine; [(7S,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methanamine
|
|
C13H21N5 |
详情 |
详情
|
(XIII) |
14451 |
[(7R,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methylamine; [(7R,9aS)-2-(2-pyrimidinyl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methanamine
|
|
C13H21N5 |
详情 |
详情
|
(XIV) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV) The acylation of aniline (I) with methanesulfonyl chloride (II) in pyridine gives the corresponding sulfonamide (III), which is submitted to a Friedel-Crafts condensation with succinic anhydride (IV) and AlCl3 in hot carbon disulfide to afford 4-[4-(methanesulfonyl)phenyl]-4-oxobutyric acid (V). The amidation of (V) with N-ethylheptylamine (VI) yields the corresponding amide (VII), which is finally reduced with LiAlH4 in THF and treated with an ethanolic solution of fumaric acid in order to precipitate the corresponding salt.
【1】
Stolle, W.T.; Stelzer, L.S.; Hester, J.B.; Perricone, S.C.; Hsi, R.S.P.; Synthesis of radiolabeled racemic and enantiomeric antiarrhythmic agents. J Label Compd Radiopharm 1994, 34, 10, 929.
|
【2】
Robinson, C.; Robinson, K.; Castaner, J.; Ibutilide Fumarate. Drugs Fut 1996, 21, 9, 894.
|
【3】
Hester, J.B. Jr. (Pharmacia Corp.); N-(Aminoalkylphenyl)sulfonamides their preparation and therapeutic use. EP 0164865; JP 1985239458; US 5155268 .
|
【4】
Hester, J.B.; Gibson, J.K.; Cimini, M.G.; Emmert, D.E.; Locker, P.K.; Perricone, S.C.; Skaletzky, L.L.; Sykes, J.K.; West, B.E.; N-[(omega-Amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with Class III antiarrhythmic activity. J Med Chem 1991, 34, 1, 308-15. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(II) |
13467 |
Methanesulfonyl chloride;Mesyl chloride;Methylsulfonyl chloride;Methanesulfonic acid chloride;Methanesulfonyl chloride;Methanesulphonyl chloride |
124-63-0 |
CH3ClO2S |
详情 | 详情
|
(III) |
13699 |
N-Phenylmethanesulfonamide; N-Phenyl methanesulfonamide
|
1197-22-4 |
C7H9NO2S |
详情 | 详情
|
(IV) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(V) |
14625 |
4-[4-[(methylsulfonyl)amino]phenyl]-4-oxobutyric acid
|
|
C11H13NO5S |
详情 |
详情
|
(VI) |
14626 |
N-ethyl-1-heptanamine; N-ethyl-N-heptylamine
|
|
C9H21N |
详情 |
详情
|
(VII) |
14627 |
N-ethyl-N-heptyl-4-[4-[(methylsulfonyl)amino]phenyl]-4-oxobutanamide
|
|
C20H32N2O4S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XII) Alternatively, the mono-methyl ester of succinic acid (XIII) was prepared by refluxing succinic anhydride (XII) with MeOH. Subsequent treatment of (XIII) with SOCl2 gave acid chloride (XIV). This was condensed with diazomethane to produce the diazo ketone (XV), which was further converted to the chloro ketone (XVI) by treatment with HCl. Condensation of chlorolevulinate (XVI) with succinimide (XVII) produced methyl delta-succinimidolevulinate (XVIII). Smooth acidic hydrolysis of the methyl ester group of (XVIII) led to the succinimido acid (XIX), which was further hydrolyzed to the succinamido acid (XX) under basic conditions. The title compound could be obtained by hydrolysis of either (XVIII), (XIX) or (XX) in refluxing 7N HCl.
【1】
Neuberger, A.; Scott, J.J.; The synhtesis of delta-succinamidolaevulic acid and related compounds. J Chem Soc 1954, 1820.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XII) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(XIII) |
55901 |
Methyl hydrogen succinate; Succinic acid monomethyl ester; Monomethyl succinate
|
3878-55-5 |
C5H8O4 |
详情 | 详情
|
(XIV) |
18060 |
4-Chloro-4-oxobutyric acid methyl ester; 3-Carbomethosypropionyl chloride; Methyl 4-chloro-4-oxobutanoate
|
1490-25-1 |
C5H7ClO3 |
详情 | 详情
|
(XV) |
59148 |
|
|
C6H8N2O3 |
详情 |
详情
|
(XVI) |
59149 |
methyl 5-chloro-4-oxopentanoate
|
|
C6H9ClO3 |
详情 |
详情
|
(XVII) |
22543 |
2,5-pyrrolidinedione
|
123-56-8 |
C4H5NO2 |
详情 | 详情
|
(XVIII) |
59150 |
methyl 5-(2,5-dioxo-1-pyrrolidinyl)-4-oxopentanoate
|
|
C10H13NO5 |
详情 |
详情
|
(XIX) |
59151 |
5-(2,5-Dioxopyrrolidin-1-yl)-4-oxopentanoic acid
|
|
C9H11NO5 |
详情 |
详情
|
(XX) |
59152 |
5-[(3-carboxypropanoyl)amino]-4-oxopentanoic acid
|
|
C9H13NO6 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(XII) The acylation of hippuric acid (LXI) with methyl succinyl chloride (XIV) in cold 4-picoline gave rise to the acyl oxazolinone (LXII). Subsequent acidic hydrolysis of (LXII) provided delta-aminolevulinic acid. In a related strategy, the lithio-dianion of ethyl hippurate (LXIII) was acylated with succinic anhydride (XII) producing the 2-amino-3-oxoadipic acid derivative (LXIV). Further hydrolysis and decarboxylation of (LXIV) under acidic conditions furnished the target compound.
【1】
Sidebottom, P.J.; Evans, D.A.; A simple route to alpha-aminoketones and related derivatives by dianion acylation reactions; an improved preparation of delta-aminolevulinic acid. J Chem Soc Chem Commun 1978, 753.
|
【2】
Aronova, N.I.; Makhova, N.N.; Zavyalov, S.I.; Volkenshtein, J.B.; Kunitskaya, G.M.; Method of producing delta-aminolevulinic acid hydrochloride. US 3846490 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XII) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(XIV) |
18060 |
4-Chloro-4-oxobutyric acid methyl ester; 3-Carbomethosypropionyl chloride; Methyl 4-chloro-4-oxobutanoate
|
1490-25-1 |
C5H7ClO3 |
详情 | 详情
|
(LXI) |
27236 |
2-(benzoylamino)acetic acid
|
495-69-2 |
C9H9NO3 |
详情 | 详情
|
(LXII) |
59186 |
methyl 4-oxo-4-(5-oxo-2-phenyl-4,5-dihydro-1,3-oxazol-4-yl)butanoate
|
|
C14H13NO5 |
详情 |
详情
|
(LXIII) |
59187 |
Ethyl hippurate
|
|
C11H13NO3 |
详情 |
详情
|
(LXIV) |
59188 |
5-(benzoylamino)-6-ethoxy-4,6-dioxohexanoic acid
|
|
C15H17NO6 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) Friedel-Crafts acylation of 2-fluorotoluene (I) with succinic anhydride (II) in the presence of AlCl3 afforded 4-(4-fluoro-3-methylphenyl)-4-oxobutanoic acid (III). Ketone (III) reduction by hydrogenation over Pd/C furnished the arylbutyric acid (IV), which was esterified to (V) by means of SOCl2 in MeOH. Subsequent aromatic ring nitration of (V) yielded (VI). After basic hydrolysis of the methyl ester of (VI), the arylbutyric acid (VII) was subjected to intramolecular cyclization in hot polyphosphoric acid producing tetralone (VIII). Reduction of the keto group of (VIII) with NaBH4, followed by dehydration of the resultant alcohol (IX) under acidic conditions, gave rise to the dihydronaphthalene (X). Hydrogenation of the olefin double bond of (X) and simultaneous nitro group reduction in the presence of PtO2 produced the amino tetralin (XI). The amino group of (XI) was further protected as the acetamide (XII) employing Ac2O and Et3N. Regioselective benzylic oxidation of (XII) with KMnO4 gave tetralone (XIII). Functionalization of the alpha position of (XIII) to ketone was achieved employing n-butyl nitrite and potassium tert-butoxide. The resulting keto oxime (XIV) was then reduced with zinc in the presence of Ac2O, yielding acetamide (XV). Both amide functions of (XV) were hydrolyzed under acidic conditions to give diamine (XVI). The aliphatic amine of (XVI) was then selectively acylated with ethyl trifluoroacetate to produce the trifluoroacetamide (XVII).
【1】
Chilman-Blair, K.; Mealy, N.E.; Castaner, J.; Bayes, M.; Exatecan Mesilate. Drugs Fut 2004, 29, 1, 9.
|
【2】
Terasawa, H.; Ejima, A.; Ohsuki, S.; Uoto, K. (Daiichi Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.); Hexacyclic cpd.. EP 0495432; JP 1993059061; US 5834476; US 6407115 .
|
【3】
Terasawa, H.; Sato, K.; Mitsui, I. (Daiichi Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.); Antitumor agents. JP 1994087746 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
52759 |
2-Fluorotoluene; o-Fluorotoluene
|
95-52-3 |
C7H7F |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
52760 |
4-(4-fluoro-3-methylphenyl)-4-oxobutanoic acid
|
|
C11H11FO3 |
详情 |
详情
|
(IV) |
52761 |
4-(4-fluoro-3-methylphenyl)butanoic acid
|
|
C11H13FO2 |
详情 |
详情
|
(V) |
52762 |
methyl 4-(4-fluoro-3-methylphenyl)butanoate
|
|
C12H15FO2 |
详情 |
详情
|
(VI) |
52763 |
methyl 4-(4-fluoro-5-methyl-2-nitrophenyl)butanoate
|
|
C12H14FNO4 |
详情 |
详情
|
(VII) |
52764 |
4-(4-fluoro-5-methyl-2-nitrophenyl)butanoic acid
|
|
C11H12FNO4 |
详情 |
详情
|
(VIII) |
52765 |
7-fluoro-8-methyl-5-nitro-3,4-dihydro-1(2H)-naphthalenone
|
|
C11H10FNO3 |
详情 |
详情
|
(IX) |
52766 |
7-fluoro-8-methyl-5-nitro-1,2,3,4-tetrahydro-1-naphthalenol
|
|
C11H12FNO3 |
详情 |
详情
|
(X) |
52767 |
6-fluoro-5-methyl-8-nitro-1,2-dihydronaphthalene
|
|
C11H10FNO2 |
详情 |
详情
|
(XI) |
52768 |
3-fluoro-4-methyl-5,6,7,8-tetrahydro-1-naphthalenylamine; 3-fluoro-4-methyl-5,6,7,8-tetrahydro-1-naphthalenamine
|
|
C11H14FN |
详情 |
详情
|
(XII) |
52769 |
N-(3-fluoro-4-methyl-5,6,7,8-tetrahydro-1-naphthalenyl)acetamide
|
|
C13H16FNO |
详情 |
详情
|
(XIII) |
52770 |
N-(3-fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthalenyl)acetamide
|
|
C13H14FNO2 |
详情 |
详情
|
(XIV) |
52771 |
N-[3-fluoro-7-(hydroxyimino)-4-methyl-8-oxo-5,8-dihydro-1(6H)-naphthalenyl]acetamide
|
|
C13H13FN2O3 |
详情 |
详情
|
(XV) |
52772 |
N-[7-(acetylamino)-3-fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthalenyl]acetamide
|
|
C15H17FN2O3 |
详情 |
详情
|
(XVI) |
52773 |
2,8-diamino-6-fluoro-5-methyl-3,4-dihydro-1(2H)-naphthalenone
|
|
C11H13FN2O |
详情 |
详情
|
(XVII) |
52774 |
N-(8-amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydro-2-naphthalenyl)-2,2,2-trifluoroacetamide
|
|
C13H12F4N2O2 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
The reaction of 4-aminobenzamidine dihydrochloride (I) with succinic anhydride and pyridine in hot DMF gives the succinyl derivative (II), which is activated with isobutyl chloroformate and N-methylmorpholine (NMM) and then coupled to 3(S)-amino-4-pentynoic acid ethyl ester (III) in DMF or DMAc.
【1】
Zablocki, J.A.; Rico, J.G.; Garland, R.B.; et al.; Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists. J Med Chem 1995, 38, 13, 2378-94. |
【2】
Graul, A.; Martel, A.M.; Castaner, J.; Xemilofiban. Drugs Fut 1997, 22, 5, 508.
|
【3】
Bovy, P.R.; Rico, J.G.; Rogers, T.E.; Tjoeng, F.S.; Zablocki, J.A. (Pharmacia Corp.); Substd. beta-amino acid derivs. useful as platelet aggregation inhibitors. EP 0542708; EP 0614360; JP 1995500111; US 5239113; WO 9307867 .
|
【4】
Process for the preparation of ethyl 3S-[4[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate. US 5536869 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(I) |
16295 |
4-aminobenzenecarboximidamide hydrochloride; 4-aminobenzamidine
|
3858-83-1 |
C7H9N3 |
详情 | 详情
|
(II) |
16296 |
4-[4-[amino(imino)methyl]anilino]-4-oxobutyric acid
|
|
C11H13N3O3 |
详情 |
详情
|
(III) |
16297 |
ethyl (3S)-3-amino-4-pentynoate
|
|
C7H11NO2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(XIII) A short and efficient synthesis of xemilofiban has been achieved as follows: The reaction of ethyl chloroformate (I) with trimethylsilylacetylene (II) by means of butyllithium gives ethyl 3-(trimethylsilyl)propyonate (III), which is condensed with the lithium salt of ethyl acetate (IV) yielding ethyl 5-(trimethylsilyl)-3-oxo-4-pentynoate (V). The selective reduction of (V) with lyophilized baker's yeast (Saccharomyces cerevisiae, Sigma type II) affords ethyl 3(R)-hydroxy-5-(trimethylsilyl)-4-pentynoate (VI), which by reaction with ammonia (VII), diethyl azodicarboxylate (VIII) and triphenylphosphine, followed by hydrolysis with water gives 3(S)-amino-5-(trimethylsilyl)-4-pentynoate (IX). Finally, this compound is condensed with N-(4-amidinophenyl)succinamic acid (XI) by means of isobutyl chloroformate and N-methylmorpholine (NMM). The intermediate succinamic acid (XI) has been obtained by condensation of 4-aminobenzamidine (XII) with succinic anhydride (XIII) in DMF.
【1】
Cossy, J.; Schmitt, A.; Cinquin, C.; Buisson, D.; Belotti, D.; A very short, efficient and inexpensive synthesis of the prodrug form of SC-54701A a platelet aggregation inhibitor. Bioorg Med Chem Lett 1997, 7, 13, 1699.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11229 |
1-[(Chlorocarbonyl)oxy]ethane;ethyl carbonochloridate; Carbonchloridic acid ethyl ester;Ethyl chloroformate;Ethyl chlorocarbonate |
541-41-3 |
C3H5ClO2 |
详情 | 详情
|
(II) |
23897 |
ethynyl(trimethyl)silane;trimethylsilyl acetylene |
1066-54-2 |
C5H10Si |
详情 | 详情
|
(III) |
23898 |
ethyl 3-(trimethylsilyl)-2-propynoate
|
29394-58-9 |
C8H14O2Si |
详情 | 详情
|
(IV) |
23899 |
lithium 1-ethoxy-1-ethylenolate
|
|
C4H7LiO2 |
详情 |
详情
|
(V) |
23900 |
ethyl 3-oxo-5-(trimethylsilyl)-4-pentynoate
|
|
C10H16O3Si |
详情 |
详情
|
(VI) |
23901 |
ethyl (3R)-3-hydroxy-5-(trimethylsilyl)-4-pentynoate
|
|
C10H18O3Si |
详情 |
详情
|
(VIII) |
20989 |
Diethylazadicarboxylate; Diethyl Azodiformate; Azodiformic Acid Diethyl Ester; Diethyl Azodicarboxylate; Azodicarboxylic Acid Diethyl Ester; Diethyl 1,2-diazenedicarboxylate
|
1972-28-7 |
C6H10N2O4 |
详情 | 详情
|
(IX) |
23904 |
ethyl (3S)-3-amino-5-(trimethylsilyl)-4-pentynoate
|
|
C10H19NO2Si |
详情 |
详情
|
(X) |
16297 |
ethyl (3S)-3-amino-4-pentynoate
|
|
C7H11NO2 |
详情 |
详情
|
(XI) |
16296 |
4-[4-[amino(imino)methyl]anilino]-4-oxobutyric acid
|
|
C11H13N3O3 |
详情 |
详情
|
(XII) |
16295 |
4-aminobenzenecarboximidamide hydrochloride; 4-aminobenzamidine
|
3858-83-1 |
C7H9N3 |
详情 | 详情
|
(XIII) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The Friedel Craft condensation of 1,3-difluorobenzene (I) with succinic anhydride (II) gives the 4-oxobutyric acid (III); which by a Wittig reaction with methylene triphenylphosphorane (IV) yields the 4-pentenoic acid (V). The condensation of (V) with the chiral auxiliary, 4(R)-benyzloxazolidin-2-one (VI) by means of pivaloyl chloride and BuLi affords the chiral imide (VII), which is submitted to a diastereoselective hydroxymethylation with trioxane and TiCl4 in THF to provide the hydroxymethyl adduct (VIII). The direct iodocyclization of (VIII) by means of I2 and pyridine in acetonitrile gives the chiral cis-tetrahydrofuran derivative (IX). The reductive cleavage of the chiral auxiliary of (IX) by means of LiBH4 in THF yields the iodoalcohol (X)???(X)a, which is condensed with 1,2,4-triazole sodium salt (XI) to afford the adduct (XII). Finally, this compound is treated with Ts-Cl and pyridine to afford the target intermediate tosylate (XIII) (see scheme no. 20027601a, intermediate no. (II)).
【1】
Saksena, A.K.; Girijavallabhan, V.M.; Wang, H.Y.; Liu, Y.T.; Pike, R.E.; Ganguly, A.K.; Concise asymmetric routes to 2,2,4-trisubstituted tetrahydrofurans via chiral titanium imide enolates: Key intermediates towards synthesis of highly active azole antifungals Sch 51048 and Sch 56592. Tetrahedron Lett 1996, 37, 32, 5657. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13095 |
m-Difluorobenzene; 1,3-Difluorobenzene
|
372-18-9 |
C6H4F2 |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
17089 |
4-(2,4-difluorophenyl)-4-oxobutyric acid
|
110931-77-6 |
C10H8F2O3 |
详情 | 详情
|
(IV) |
27301 |
methylene(triphenyl)phosphorane
|
|
C19H17P |
详情 |
详情
|
(V) |
17090 |
4-(2,4-difluorophenyl)-4-pentenoic acid
|
|
C11H10F2O2 |
详情 |
详情
|
(VI) |
25351 |
(4R)-4-benzyl-1,3-oxazolidin-2-one; (R)-(+)-4-benzyl-2-oxazolidinone
|
102029-44-7 |
C10H11NO2 |
详情 | 详情
|
(VII) |
58310 |
(4R)-4-benzyl-3-[4-(2,4-difluorophenyl)-4-pentenoyl]-1,3-oxazolidin-2-one
|
|
C21H19F2NO3 |
详情 |
详情
|
(VIII) |
58311 |
(4R)-4-benzyl-3-[(2S)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-pentenoyl]-1,3-oxazolidin-2-one
|
|
C22H21F2NO4 |
详情 |
详情
|
(IX) |
58312 |
(4R)-4-benzyl-3-{[(3S,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydro-3-furanyl]carbonyl}-1,3-oxazolidin-2-one
|
|
C22H20F2INO4 |
详情 |
详情
|
(X) |
17096 |
[(3R,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydro-3-furanyl]methanol
|
|
C12H13F2IO2 |
详情 |
详情
|
(XI) |
16341 |
1H-1,2,4-triazol-1-ylsodium
|
|
C2H2N3Na |
详情 |
详情
|
(XII) |
16343 |
[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methanol
|
|
C14H15F2N3O2 |
详情 |
详情
|
(XIII) |
16311 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-methylbenzenesulfonate
|
|
C21H21F2N3O4S |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(XXXV) 3) The Friedel Crafts condensation of m-difluorobenzene (XXXIV) with succinic anhydride (XXXV) gives 4-(2,4-difluorophenyl)-4-oxobutyric acid (XXXVI), which is converted by a Wittig reaction into 4-(2,4-difluorophenyl)-4-pentenoic acid (XXXVII) and subsequently into its acyl chloride (XXXVIII). The condensation of (XXXVIII) with 4(R)-benzyloxazolidin-2-one (XXXIX) gives the acyl oxazolidinone (XL), which is regioselectively hydroxymethylated with 1,3,5-trioxane and TiCl4 to afford 4(R)-benzyl-3-[4-(2,4-difluorophenyl)-3(S)-(hydroxymethyl)-4-pentenoyl] oxazolidin-2-one (XLI). The cyclization of (XLI) with iodine and pyridine yields the tetrahydrofuran derivative (XLII), which is reduced with LiBH4 to (5R-cis)-5-(2,4-difluoromethyl)-5-(iodomethyl)tetrahydrofuran-3-methanol (XLIII). Finally, this compound is condensed with sodium 1,2,4-triazole (XXXI) to afford (5R-cis)-5-(2,4-difluoromethyl)-5-(1,2,4-triazol-1-ylmethyl) tetrahydrofuran-3-methanol (XXXIII), already obtained in Scheme 22656201c.
【1】
Fromtling, R.A.; Castañer, J.; SCH-56592. Drugs Fut 1996, 21, 2, 160.
|
【2】
Girijavallabhan, V.M.; Saksena, A.K.; Lovey, R.G.; Bennett, F.; Pike, R.E.; Wang, H.; Pinto, P.; Liu, Y.T.; Patel, N.; Ganguly, A.K.; SCH-56592, a novel orally active broad spectrum antifungal agent. 35th Intersci Conf Antimicrob Agents Chemother (Sept 17-20, San Francisco) 1995, Abst F61. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IXL) |
17092 |
(4R)-4-heptyl-1,3-oxazolan-2-one
|
|
C10H19NO2 |
详情 |
详情
|
(XXXI) |
13104 |
1,2,4-Triazole, sodium derivative
|
41253-21-8 |
C2H2N3Na |
详情 | 详情
|
(XXXIII) |
16343 |
[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methanol
|
|
C14H15F2N3O2 |
详情 |
详情
|
(XXXIV) |
13095 |
m-Difluorobenzene; 1,3-Difluorobenzene
|
372-18-9 |
C6H4F2 |
详情 | 详情
|
(XXXV) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(XXXVI) |
17089 |
4-(2,4-difluorophenyl)-4-oxobutyric acid
|
110931-77-6 |
C10H8F2O3 |
详情 | 详情
|
(XXXVII) |
17090 |
4-(2,4-difluorophenyl)-4-pentenoic acid
|
|
C11H10F2O2 |
详情 |
详情
|
(XXXVIII) |
17091 |
4-(2,4-difluorophenyl)-4-pentenoyl chloride
|
|
C11H9ClF2O |
详情 |
详情
|
(XXXIX) |
17092 |
(4R)-4-heptyl-1,3-oxazolan-2-one
|
|
C10H19NO2 |
详情 |
详情
|
(XL) |
17093 |
(4R)-3-[4-(2,4-difluorophenyl)-4-pentenoyl]-4-heptyl-1,3-oxazolan-2-one
|
|
C21H27F2NO3 |
详情 |
详情
|
(XLI) |
17094 |
(4R)-3-[(2S)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-pentenoyl]-4-heptyl-1,3-oxazolan-2-one
|
|
C22H29F2NO4 |
详情 |
详情
|
(XLII) |
17095 |
(4R)-3-[[(3S,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydro-3-furanyl]carbonyl]-4-heptyl-1,3-oxazolan-2-one
|
|
C22H28F2INO4 |
详情 |
详情
|
(XLIII) |
17096 |
[(3R,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydro-3-furanyl]methanol
|
|
C12H13F2IO2 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(II) The Friedel Craft's condensation of 2-methyl-2-phenylpropionic acid methyl ester (I) with succinic anhydride (II) by means of AlCl3 in CS2 or dichloromethane/nitrobenzene gives 2-[4-(hydroxysuccinyl)phenyl]-2-methylpropionic acid methyl ester (III) (purified through its phenethylamine salt), which is condensed with 4-(1-hydroxy-1,1-diphenylmethyl)piperidine (IV) by means of ethyl chloroformate and TEA in THF or with DCC and p-nitrophenol in ethyl acetate to yield the adduct (V). The reduction of the oxo groups of (V) by means of BH3/Me2S in THF affords the ester precursor (VI), which is finally hydrolyzed with NaOH in refluxing methanol to provide the target compound.
【1】
Schroeder, C.; Huddleston, R.; Charles, R. (Aventis Pharma Deutschland GmbH); Process for the production of the piperidine deriv. fexofenadine. WO 02102776 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
58227 |
methyl 2-methyl-2-phenylpropanoate; Methyl alpha,alpha-dimethylbenzeneacetate
|
|
C11H14O2 |
详情 |
详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
58228 |
4-[4-(2-methoxy-1,1-dimethyl-2-oxoethyl)phenyl]-4-oxobutanoic acid
|
|
C15H18O5 |
详情 |
详情
|
(IV) |
17178 |
diphenyl(4-piperidinyl)methanol; alpha,alpha-Diphenyl-4-piperidinomethanol; Azacyclonol
|
115-46-8 |
C18H21NO |
详情 | 详情
|
(V) |
58229 |
methyl 2-[4-(4-{4-[hydroxy(diphenyl)methyl]-1-piperidinyl}-4-oxobutanoyl)phenyl]-2-methylpropanoate
|
|
C33H37NO5 |
详情 |
详情
|
(VI) |
58230 |
methyl 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]-1-piperidinyl}butyl)phenyl]-2-methylpropanoate
|
|
C33H41NO4 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(V) The condensation of doxorubicin (I) with Fmoc-beta-alanyl-L-leucyl-L-alanyl-L-leucine (II) by means of HATU and DIEA in DMF gives the protected adduct (III), which is treated with piperidine in DMF to yield the deprotected adduct (IV). Finally, this compound is condensed with succinic anhydride (V) in the same solvent and treated with NaOH or NaHCO3 to afford the target sodium salt.
【1】
Fernandez, A.-M.; et al.; N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: An extracellularly tumor-activated prodrug devoid of intravenous acute toxicity. J Med Chem 2001, 44, 22, 3750.
|
【2】
Lobl, T.J.; Trouet, A.; Fernandez, A.-M.; Nieder, M.H.; Yarranton, G.T.; Gangwar, S.; Viski, P.; Lewis, E.; Dubois, V. (Beckman Coulter, Inc.); Prodrug cpds. and process for preparation thereof. WO 0033888 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49366 |
(9S,12S,15S)-1-(9H-fluoren-9-yl)-9,15-diisobutyl-12-methyl-3,7,10,13-tetraoxo-2-oxa-4,8,11,14-tetraazahexadecan-16-oic acid
|
|
C33H44N4O7 |
详情 |
详情
|
(II) |
11675 |
(8S,10S)-10-[[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-8-glycoloyl-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione
|
|
C27H29NO11 |
详情 |
详情
|
(III) |
49367 |
9H-fluoren-9-ylmethyl 3-([(1S)-1-[([(1S)-2-[((1S)-1-[[((2S,3S,4S,6R)-6-[[(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-3-hydroxy-2-methyltetrahydro-2H-pyran-4-yl)amino]carbonyl]-3-methylbutyl)amino]-1-methyl-2-oxoethyl]amino)carbonyl]-3-methylbutyl]amino)-3-oxopropylcarbamate |
|
C60H71N5O17 |
详情 |
详情
|
(IV) |
49368 |
(2S)-2-[(3-aminopropanoyl)amino]-N-[(1S)-2-[((1S)-1-[[((2S,3S,4S,6R)-6-[[(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-3-hydroxy-2-methyltetrahydro-2H-pyran-4-yl)amino]carbonyl]-3-methylbutyl)amino]-1-methyl-2-oxoethyl]-4-methylpentanamide |
|
C45H61N5O15 |
详情 |
详情
|
(V) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) Esterification of probucol (I) with succinic anhydride (II) in the presence of NaH afforded the title monosuccinate ester, which was separated from the unreacted probucol (I) and the corresponding disuccinate ester by column chromatography. Esterification of (I) was also reported in the presence of other bases, such as potassium tert-butoxide, KOH, DMAP and DABCO.
【2】
Meng, C.Q.; Somers, P.K.; Rachita, C.L.; Holt, L.A.; Hoong, L.K.; Zehng, X.S.; Simpson, J.E.; Hill, R.R.; Olliff, L.K.; Kunsch, C.; Sundell, C.L.; Parthasarathy, S.; Saxena, U.; Sikorski, J.A.; Wasserman, M.A.; Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis. Bioorg Med Chem Lett 2002, 12, 18, 2545. |
【1】
Sorbera, L.A.; Castaner, J.; AGI-1067. Drugs Fut 2003, 28, 5, 421.
|
【3】
Jass, P.A.; Process for preparing probucol derivs.. US 6323359 .
|
【4】
Medford, R.M.; Meng, C.Q.; Hoong, L.K.; Somers, P.K. (AtheroGenics, Inc.); Cpds. and methods for the inhibition of the expression of VCAM-1. JP 2002503227; US 6147250; WO 9851662 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
55055 |
2,6-di(tert-butyl)-4-[(1-{[3,5-di(tert-butyl)-4-hydroxyphenyl]sulfanyl}-1-methylethyl)sulfanyl]phenol
|
|
C31H48O2S2 |
详情 |
详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(I) The reaction of succinic anhydride (I) with the lithium salt of the chiral oxazolidinone (II) in THF gives 3-(hydroxysucccinyl)-4(S)-isopropyloxazolidin-2-one (III), which is treated successively with oxalyl chloride, CH2N2 and HBr to yield the bromomethyl derivative (IV). The cyclization of (IV) with thiourea in refluxing isopropanol affords the 2-aminothiazol derivative (V), which is protected with 2,2,2-trichloroethyl chloroformate by means of DIEA and DMAP in dichloromethane giving the carbamate (VI). The reaction of (VI) with tert-butyl 2-bromoacetate (VII) by means of sodium hexamethyldisilazane (NaHMDS) in THF yields the chiral butyrate (VIII), which is hydrolyzed with TFA in dichloromethane to the chiral butyric acid (IX). The condensation of (IX) with the intermediate amine (X) by means of BOP-PF6 and DIEA in DMF affords the corresponding amide (XI), which is treated with magnesium methoxide in methanol to eliminate the oxazolidinone group (the chiral inductor) providing the methyl ester (XII). The hydrolysis of (XII) with NaOH, followed by condensation with amine (XIII) (J Org Chem 1988, 53: 6109; J Med Chem 1993, 36: 449) gives the protected intermediate (XIV), which is finally deprotected by reaction with Zn/HCl in aqueous dioxane.
【1】
Simoneau, B.; Lavallee, P.; Anderson, P.C.; et al.; Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy. Bioorg Med Chem 1999, 7, 3, 489.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
|
13664 |
1,1,1-Trichloro-2-[(chlorocarbonyl)oxy]ethane; 2,2,2-Trichloroethyl chloroformate
|
17341-93-4 |
C3H2Cl4O2 |
详情 | 详情
|
(I) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(II) |
29533 |
[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]lithium
|
|
C6H10LiNO2 |
详情 |
详情
|
(III) |
29534 |
4-[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]-4-oxobutyric acid
|
|
C10H15NO5 |
详情 |
详情
|
(IV) |
29535 |
5-bromo-1-[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]-1,4-pentanedione
|
|
C11H16BrNO4 |
详情 |
详情
|
(V) |
29536 |
(4S)-3-[3-(2-amino-1,3-thiazol-4-yl)propanoyl]-4-isopropyl-1,3-oxazolidin-2-one
|
|
C12H17N3O3S |
详情 |
详情
|
(VI) |
29537 |
2,2,2-trichloroethyl 4-[3-[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]-3-oxopropyl]-1,3-thiazol-2-ylcarbamate
|
|
C15H18Cl3N3O5S |
详情 |
详情
|
(VII) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(VIII) |
29538 |
tert-butyl (3R)-4-[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]-4-oxo-3-[(2-[[(2,2,2-trichloroethoxy)carbonyl]amino]-1,3-thiazol-4-yl)methyl]butanoate
|
|
C21H28Cl3N3O7S |
详情 |
详情
|
(IX) |
29539 |
(3R)-4-[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]-4-oxo-3-[(2-[[(2,2,2-trichloroethoxy)carbonyl]amino]-1,3-thiazol-4-yl)methyl]butyric acid
|
|
C17H20Cl3N3O7S |
详情 |
详情
|
(X) |
29540 |
2-[(cyclohexylmethyl)amino]-N-methyl-N-[2-(2-pyridinyl)ethyl]acetamide
|
|
C17H27N3O |
详情 |
详情
|
(XI) |
29541 |
2,2,2-trichloroethyl 4-((2R)-4-[(cyclohexylmethyl)(2-[methyl[2-(2-pyridinyl)ethyl]amino]-2-oxoethyl)amino]-2-[[(4S)-4-isopropyl-2-oxo-1,3-oxazolidin-3-yl]carbonyl]-4-oxobutyl)-1,3-thiazol-2-ylcarbamate
|
|
C34H45Cl3N6O7S |
详情 |
详情
|
(XII) |
29542 |
methyl (2R)-4-[(cyclohexylmethyl)(2-[methyl[2-(2-pyridinyl)ethyl]amino]-2-oxoethyl)amino]-4-oxo-2-[(2-[[(2,2,2-trichloroethoxy)carbonyl]amino]-1,3-thiazol-4-yl)methyl]butanoate
|
|
C29H38Cl3N5O6S |
详情 |
详情
|
(XIII) |
29543 |
(2S,3R,4S)-2-amino-1-cyclohexyl-6-methyl-3,4-heptanediol
|
|
C14H29NO2 |
详情 |
详情
|
(XIV) |
29544 |
2,2,2-trichloroethyl 4-[(2R)-2-([[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]amino]carbonyl)-4-[(cyclohexylmethyl)(2-[methyl[2-(2-pyridinyl)ethyl]amino]-2-oxoethyl)amino]-4-oxobutyl]-1,3-thiazol-2-ylcarbamate
|
|
C42H63Cl3N6O7S |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) By condensation of biphenyl (I) and succinic anhydride (II) in nitrobenzene, using AlCl3, as catalyst.
【1】
Castañer, J.; Fenbufen. Drugs Fut 1976, 1, 1, 21.
|
【2】
Tomeufeik, A.; et al. (American Cyanamid Co.); Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain. DE 2147111; FR 2107848; GB 1320076; US 3784701 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
22523 |
1-nitrobenzene
|
28250-14-8 |
C6H5NO2 |
详情 | 详情
|
(I) |
31202 |
1,1'-biphenyl
|
92-52-4 |
C12H10 |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线24
该中间体在本合成路线中的序号:
(II) The title compound is a semisynthetic derivative of triptolide (I), a substance isolated from the root xylem of the Chinese medicinal plant Tripterygium wilfordii. Condensation of (I) with succinic anhydride (II) in hot pyridine furnished the corresponding hemisuccinate ester. This was converted to the corresponding sodium salt by treatment with aqueous NaHCO3 and then isolated by lyophilization of the filtered solution.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51397 |
(3bS,4aS,5aS,6S,6aR,7aS,7bS,8aS,8bS)-6-hydroxy-6a-isopropyl-8b-methyl-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydrotrioxireno[2',3':6,7:2',3':8a,9:2',3':4b,5]phenanthro[1,2-c]furan-1(3H)-one
|
|
C20H24O6 |
详情 |
详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(VI) Coupling of PhCH2OOC-Pro-OH (I) with diphenyl (1-amino-2-phenylethyl)phosphonate (II) by means of DCC in THF affords derivative (III), which is then subjected to hydrogenation followed by coupling with PhCH2OOC -Val-OH (IV) by means of DCC to provide peptide derivative (V). Finally, reaction of (V) with succinic anhydride in EtOAc under an atmosphere of H2 in the presence of Pd/C provides the target compound.
【1】
Oleksyszym, J.; Powers, J.C.; Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. Biochemistry 1991, 30, 2, 485.
|
【2】
Powers, J.C.; Ni, L.; Jackson, D.S. (Georgia Technology Research Corp.); Basic alpha-aminoalkylphosphonate derivs.. US 5952307 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19113 |
(2S)-1-[(benzyloxy)carbonyl]-2-pyrrolidinecarboxylic acid
|
1148-11-4 |
C13H15NO4 |
详情 | 详情
|
(II) |
44216 |
diphenyl (1R)-1-amino-2-phenylethylphosphonate
|
|
C20H20NO3P |
详情 |
详情
|
(III) |
44217 |
benzyl (2S)-2-([[(1R)-1-(diphenoxyphosphoryl)-2-phenylethyl]amino]carbonyl)-1-pyrrolidinecarboxylate
|
|
C33H33N2O6P |
详情 |
详情
|
(IV) |
18092 |
(2S)-2-[[(benzyloxy)carbonyl]amino]-3-methylbutyric acid
|
|
C13H17NO4 |
详情 |
详情
|
(V) |
44218 |
diphenyl (1R)-1-([[(2S)-1-((2S)-2-[[(benzyloxy)carbonyl]amino]-3-methylbutanoyl)pyrrolidinyl]carbonyl]amino)-2-phenylethylphosphonate
|
|
C38H42N3O7P |
详情 |
详情
|
(VI) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
(III) 5-Iodo-2'-deoxyuridine (I) is protected at the primary hydroxyl group with 4,4'-dimethoxytrityl chloride to afford the 5'-O-trityl derivative (II). Subsequent esterification of the remaining hydroxyl group of (II) with succinic anhydride (III) yields the succinate mono-ester (IV). Acid (IV) is then coupled with diethylene glycol in the presence of DCC to produce (V). The O-trityl group of (V) is finally removed by treatment with formic acid, to give the title compound.
【1】
Bonina, F.P.; et al.; New oligoethylene ester derivatives of 5-iodo-2'-deoxyuridine as dermal prodrugs: Synthesis, physicochemical properties, and skin permeation studies. J Pharm Sci 2002, 91, 1, 171.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31154 |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione
|
54-42-2 |
C9H11IN2O5 |
详情 | 详情
|
(II) |
57566 |
1-((2R,4S,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-4-hydroxytetrahydro-2-furanyl)-5-iodo-2,4(1H,3H)-pyrimidinedione
|
|
C30H29IN2O7 |
详情 |
详情
|
(III) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(IV) |
57567 |
4-({(2R,3S,5R)-2-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-5-[5-iodo-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-3-furanyl}oxy)-4-oxobutanoic acid
|
|
C34H33IN2O10 |
详情 |
详情
|
(V) |
57568 |
1-{(2R,3S,5R)-2-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-5-[5-iodo-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-3-furanyl} 4-[2-(2-hydroxyethoxy)ethyl] succinate
|
|
C38H41IN2O12 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(III) 5-Iodo-2'-deoxyuridine (I) is protected at the primary hydroxyl group with 4,4'-dimethoxytrityl chloride to afford the 5'-O-trityl derivative (II). Subsequent esterification of the remaining hydroxyl group of (II) with succinic anhydride (III) yields the succinate mono-ester (IV). Acid (IV) is then coupled with triethylene glycol in the presence of DCC to produce (V). The O-trityl group of (V) is finally removed by treatment with formic acid, to give the title compound.
【1】
Bonina, F.P.; et al.; New oligoethylene ester derivatives of 5-iodo-2'-deoxyuridine as dermal prodrugs: Synthesis, physicochemical properties, and skin permeation studies. J Pharm Sci 2002, 91, 1, 171.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31154 |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione
|
54-42-2 |
C9H11IN2O5 |
详情 | 详情
|
(II) |
57566 |
1-((2R,4S,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-4-hydroxytetrahydro-2-furanyl)-5-iodo-2,4(1H,3H)-pyrimidinedione
|
|
C30H29IN2O7 |
详情 |
详情
|
(III) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(IV) |
57567 |
4-({(2R,3S,5R)-2-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-5-[5-iodo-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-3-furanyl}oxy)-4-oxobutanoic acid
|
|
C34H33IN2O10 |
详情 |
详情
|
(V) |
57569 |
1-{(2R,3S,5R)-2-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-5-[5-iodo-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-3-furanyl} 4-{2-[2-(2-hydroxyethoxy)ethoxy]ethyl} succinate
|
|
C40H45IN2O13 |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(VI) Condensation of paclitaxel (V) with succinic anhydride (VI) affords the hemisuccinate ester (VII). This is subsequently coupled with amino ester (IV) in the presence of DCC to furnish the title compound.
【1】
Jacob, J.N. (Organomed Corporation); Paclitaxel-carbohydrate conjugates: Design, synthesis and biological evaluations. US 6218367 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
59013 |
(3R,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl 4-aminobutanoate
|
|
C10H19NO7 |
详情 |
详情
|
(V) |
10595 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
33069-62-4 |
C47H51NO14 |
详情 | 详情
|
(VI) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(VII) |
59014 |
4-{[(1R,2S)-2-(benzoylamino)-1-({[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-2-(benzoyloxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-15-yl]oxy}carbonyl)-2-phenylethyl]oxy}-4-oxobutano
|
|
C51H55NO17 |
详情 |
详情
|
合成路线29
该中间体在本合成路线中的序号:
(II) Tetrahydrocannabinol hemisuccinate is prepared by acylation of tetrahydrocannabinol (I) with succinic anhydride (II) in the presence of a variety of organic and inorganic bases.
【1】
Elsohly, M.A.; Ross, S.A.; Feng, S. (University of Mississippi); Method of preparing delta-9-tetrahydrocannabinol esters. GB 2358397; US 6008383; WO 0029402 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
58450 |
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; delta 1-tetrahydrocannabinol
|
|
C21H30O2 |
详情 |
详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线30
该中间体在本合成路线中的序号:
(VIII) Hydroboration of the double bond of (VI), followed by quenching with NaBO3 yields the primary alcohol (VII). This is then acylated by succinic anhydride (VIII) in the presence of DMAP to provide the target succinate ester.
【1】
Posner, G.H.; Paik, I.-P.; Sur, S.; McRiner, A.J.; Borstnik, K.; Zie, S.; Shapiro, T.A.; Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. J Med Chem 2003, 46, 6, 1060.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
64028 |
(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-10-(2-{[(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0~4,13~.0~8,13~]hexadec-10-yl]methyl}-2-propenyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.0~4,13~.0~8,13~]hexadecane |
|
C34H52O8 |
详情 |
详情
|
(VII) |
64030 |
3-[(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0~4,13~.0~8,13~]hexadec-10-yl]-2-{[(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0~4,13~.0~8,13~]hexadec-10-yl]methyl}-1-propanol |
|
C34H54O9 |
详情 |
详情
|
(VIII) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|